Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-14

Clinical Trial Update: Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Miralax (PEG 3350) to Golytely for bowel preparation prior to screening colonoscopy; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GoLYTELY
  • MIRALAX (POLYETHYLENE GLYCOL 3350)

Snippet

Sponsor: Temple University | Conditions: Colon Cancer | Phase 4 | Status: COMPLETED | Results posted: 2016-06-14